Key Record Dates
ClinicalTrials.gov Identifier: | NCT03149822 |
---|---|
Brief Title: | Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma |
First Submitted : | April 28, 2017 |
First Submitted that Met QC Criteria : | May 10, 2017 |
First Posted : | May 11, 2017 |
Last Update Submitted that Met QC Criteria : | March 19, 2021 |
Last Update Posted : | March 23, 2021 |